Internal Medicine, Nephrology · Dallas, TX
NPI
1811308687
Since 2014
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
411 N Washington Ave Ste 6000
Dallas, TX, 75246
Phone (214) 358-2300
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
876 services
Medicare patients, 2024
245
Average age 69
Drug cost, 2024
$291K
492 prescriptions
Company payments, 2025
$114
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahbaz Ahmed was code 99233 (hospital e&m - subsequent), 219 times for 91 patients. In total Shahbaz Ahmed billed 876 services in 24 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 219 | 91 | $87.82 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 122 | 58 | $60.97 | $7,438 |
| 99214 Office E&M - Established | Office | 101 | 56 | $73.74 | $7,448 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 94 | 53 | $12.47 | $1,172 |
| 99223 Hospital E&M - Initial | Facility | 70 | 68 | $132.20 | $9,254 |
| 90935 Hemodialysis | Facility | 27 | 21 | $54.71 | $1,477 |
| 99291 Critical Care E&M | Facility | 20 | 14 | $160.47 | $3,209 |
| 99204 Office E&M - New | Office | 16 | 16 | $125.44 | $2,007 |
By year: 2022 $126K for 5,453 services; 2023 $98K for 3,328 services; 2024 $80K for 876 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shahbaz Ahmed prescribed most often to Medicare patients was Zerbaxa (Ceftolozane/Tazobactam), with 29 prescriptions and refills. In total Shahbaz Ahmed wrote 492 Medicare prescriptions that cost $291K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Zerbaxa Ceftolozane/Tazobactam | 29 | 29 | Under 11 | $146K |
| Nifedipine Er Nifedipine | 28 | 66 | 12 | $765 |
| Losartan Potassium Generic | 26 | 62 | 11 | $192 |
| Sevelamer Carbonate Generic | 26 | 72 | 12 | $9,962 |
| Furosemide Generic | 25 | 62 | 13 | $240 |
| Torsemide Generic | 19 | 52 | Under 11 | $568 |
| Farxiga Dapagliflozin Propanediol | 18 | 48 | Under 11 | $26K |
| Velphoro Sucroferric Oxyhydroxide | 17 | 21 | Under 11 | $65K |
| Amlodipine Besylate Generic | 15 | 41 | Under 11 | $114 |
| Bumetanide Generic | 15 | 37 | Under 11 | $536 |
| Tamsulosin Hcl Generic | 15 | 41 | Under 11 | $320 |
| Spironolactone Generic | 14 | 42 | Under 11 | $211 |
| Calcitriol Generic | 13 | 37 | Under 11 | $300 |
| Calcium Acetate Generic | 12 | 32 | Under 11 | $2,446 |
| Carvedilol Generic | 12 | 34 | Under 11 | $88.88 |
Brand drugs: 98 claims; generic drugs: 394 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shahbaz Ahmed $114 ($114 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $75.84.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.